Skip to NavigationSkip to content

Features

Spending time to understand your users can have significant benefits for your web strategy.

As the forthcoming enlargement of the EU will push global marketing even further to the front of the agenda, what does it mean for the pharma...

Once blacklisted, NRT prescriptions almost tripled in 2002 and are now central to the Government's war on smoking. Pharmafocus investigates this...

Pharma is often seen as an ideal industry to benefit from e-learning but how should it be implemented and what do the companies themselves think...

How do private pharmaceutical companies in Europe compare with their public counterparts and how might they compete in fut

How can biotech companies grow while keeping their innovative nature?

How can biotech companies avoid the organisational straitjacket restricting pharma?

Testing pharmaceutical adverts in front of doctors is a well-worn practice, but perhaps one that could do with updating as both the NHS and pharma...

A GP's view on how the use of opinion leaders by pharma should be handled

An agency's view on managing opinion leader relationships